PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34894066-2	2022	Imatinib, a receptor tyrosine kinase (RTK) inhibitor, has been used in Penttinen syndrome (PS) patients with good results.	Imatinib Mesylate	0-8	ret proto-oncogene	Homo sapiens	12-36	
34894066-2	2022	Imatinib, a receptor tyrosine kinase (RTK) inhibitor, has been used in Penttinen syndrome (PS) patients with good results.	Imatinib Mesylate	0-8	ret proto-oncogene	Homo sapiens	38-41